Found 2026 matching trials
A Prospective Study of HBV Immunity and HBV Vaccination in Patients With NAFLD in Canada
N/A(1) Due to missed childhood vaccination programs, the majority of adult pat...
Location
University of Calgary
First-In-Human Study of ChAdOx1-HBV & MVA-HBV Vaccines (VTP-300) for Chronic HBV
PHASE1This is an open-label study to determine the safety, tolerability and immun...
Location
Pusan National University Hospital
Emtricitabine for Naive Chinese Chronic Hepatitis B Patients
PHASE4This study evaluates generic emtricitabine(FTC) in Chinese naive chronic he...
Location
Multiple Locations
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HbeAg-negative Chronic Hepatitis B (Perseas)
N/AThis observational, multi-center, open-label study will evaluate the progno...
Location
Multiple Locations
A Phase I Clinical Study of AHB - 171 in Healthy Participants(HP) and Chronic Hepatitis B (CHB) Participants
PHASE1The goal of this clinical trial is to evaluate the safety, tolerability, im...
Location
AusperBio Investigational Site
Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection
PHASE2The goals of this clinical study are to compare the effectiveness, safety a...
Status
Active Not Recruiting
Location
Children's Hospital of Los Angeles
Phase I Safety and Tolerability Study of Birinapant in Chronic Hepatitis B
PHASE1This study evaluates the addition of birinapant in subjects with chronic He...
Location
CMAX / Royal Adelaide Hospital
ShearWave™ Elastography to Assess Liver Fibrosis in Chinese Patients With Hepatitis B
N/AThis study will evaluate how liver stiffness measurements made with ShearWa...
Location
People's Liberation Army General(301)Hospital
Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection
PHASE2This is a phase 2 study in which participants with chronic hepatitis B viru...
Location
Investigative Site
Activity of NCO-48 Fumarate in Treatment-Naive Adults With Chronic Hepatitis B
PHASE1This is an open-label study evaluating multiple doses of NCO-48 Fumarate ve...
Location
National Institute of Clinical Research, Inc